SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

        Date of Report (Date of earliest event reported): August 23, 2006

                         SYNOVIS LIFE TECHNOLOGIES, INC.
             (Exact name of Registrant as specified in its charter)

                        State of Incorporation: Minnesota
                          Commission File No.: 0-13907
                 I.R.S. Employer Identification No.: 41-1526554

                     Address of principal executive offices:
                             2575 University Ave. W.
                            St. Paul, Minnesota 55114

                        Telephone Number: (651) 796-7300

                                   ----------

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ]  Written communications pursuant to Rule 425 under the Securities Act (17
     CFR 230.425)

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the
     Exchange Act (17 CFR 240.14d-2(b))

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the
     Exchange Act (17 CFR 240.13e-4(c))



ITEM 2.02 RESULTS OF OPERATIONS AND FINANCIAL CONDITION

On August 23, 2006, Synovis Life Technologies, Inc. (Synovis) issued a press
release announcing its earnings for the three and nine months ended July 31,
2006. A copy of the press release is furnished herewith as Exhibit 99.1. Synovis
will also publish the press release, including the supplemental information
contained therein, on its website at www.synovislife.com.

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

     (c)  Exhibits.

          (99.1) Synovis Life Technologies, Inc. News Release dated August 23,
                 2006.



                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.

                                        SYNOVIS LIFE TECHNOLOGIES, INC.


Dated: August 23, 2006                  By: /s/ Brett Reynolds
                                            ------------------------------------
                                            Brett Reynolds
                                            Vice-President of Finance,
                                            Chief Financial Officer and
                                            Corporate Secretary



                                  EXHIBIT INDEX



EXHIBIT NO.                    DESCRIPTION                          METHOD OF FILING
-----------                    -----------                          ----------------
                                                       
(99.1)        Synovis Life Technologies, Inc. News Release   Filed herewith electronically.
              dated August 23, 2006